ArticleOncoTargets and therapy2019

miR-492 Promotes Cancer Progression by Targeting GJB4 and Is a Novel Biomarker for Bladder Cancer.

Kai Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.